Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | -0.05% | 518.57 | 1.0% | $823.56m | |
| DHR | Danaher Corp. | -0.02% | 238.10 | 0.7% | $584.68m | |
| ABT | Abbott Laboratories | 0.24% | 115.00 | 0.8% | $502.06m | |
| ISRG | Intuitive Surgical, Inc. | 0.00% | 752.01 | 2.3% | $472.48m | |
| MDT | Medtronic Plc | -0.01% | 116.89 | 0.6% | $422.02m | |
| BSX | Boston Scientific Corp. | 0.03% | 36.79 | 1.0% | $357.42m | |
| DXCM | DexCom, Inc. | 0.00% | 376.39 | 7.8% | $352.22m | |
| BDX | Becton, Dickinson & Co. | 0.07% | 260.41 | 1.0% | $304.09m | |
| QDEL | Quidel Corp. | 0.00% | 238.49 | 7.7% | $249.44m | |
| SYK | Stryker Corp. | 0.01% | 239.58 | 1.3% | $237.66m | |
| ALGN | Align Technology, Inc. | 0.00% | 539.47 | 6.4% | $223.74m | |
| A | Agilent Technologies, Inc. | 0.94% | 126.72 | 1.6% | $200.88m | |
| EW | Edwards Lifesciences Corp. | -0.02% | 85.87 | 0.4% | $196.51m | |
| BAX | Baxter International, Inc. | -0.01% | 80.09 | 1.8% | $182.40m | |
| ZBH | Zimmer Biomet Holdings, Inc. | -0.10% | 159.15 | 1.7% | $170.31m |
Company Profile
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.